Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Open in API
Filings indexed 1,740 across all filing types
Latest filing 2021-12-17 Director's Dealing
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
110年12月16日內部人設質解質
Director's Dealing Classification · 100% confidence The document is a short tabular report showing a pledge of shares by a company director or executive, including details such as the number of shares pledged and the pledgee. This matches the description of a Director's Dealing report, which covers personal share transactions by company directors and executives. The document length is very short and contains specific insider share transaction data, confirming it is a Director's Dealing report rather than a general regulatory filing or other category.
2021-12-17 Chinese
110年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (華廣) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements, no management discussion, no audit information, no voting results, no legal proceedings, and no mention of any report publication or meeting. The content is regulatory in nature, providing compliance-related financial data but not constituting a full report or announcement of a report. The document length is very short (601 characters), and it does not indicate it is an announcement of a report publication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-12-10 Chinese
110年11月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 華廣, with data presented in a tabular format. It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document length is short (773 characters) and it does not contain detailed financial statements or comprehensive analysis. It appears to be a regulatory disclosure of revenue figures rather than a full financial report or earnings release. There is no indication of an earnings announcement, management discussion, or detailed financial data beyond revenue figures. Given the nature and brevity, this fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-12-10 Chinese
110年12月法人說明會簡報 — 473720211209E001.pdf
Annual Report Classification · 95% confidence The document provides a detailed company profile, including establishment date, business overview, product lines, subsidiaries, and extensive financial data spanning multiple years (2017 to 2021 Q3). It includes financial metrics such as net revenue, gross profit, net income, EPS, sales regions, product sales breakdown, and dividend history. The length of the document (7,103 characters) and the depth of financial and operational information indicate it is a comprehensive report rather than a brief announcement or presentation. There is no indication that this is a transcript, proxy statement, or regulatory filing. The presence of multi-year financial data and business overview aligns with characteristics of an Annual Report. Therefore, the document is best classified as an Annual Report (10-K). 9M 2021
2021-12-09 Chinese
110年12月法人說明會簡報 — 473720211209M001.pdf
Investor Presentation Classification · 95% confidence The document is titled as a 2021 online institutional investor presentation (法人說明會 translates to 'investor presentation'). It contains company overview, product descriptions, global organization, sales and profit data, revenue breakdown by region, product sales proportions, and dividend history. The content is typical of an investor presentation focusing on business strategy, product ecosystem, and financial highlights rather than a formal annual or quarterly report. There is no indication of full financial statements or detailed management discussion and analysis that would classify it as an Annual Report (10-K) or Interim Report (IR). The document length is about 5,366 characters, which is consistent with a presentation rather than a full report. Therefore, the best fitting category is Investor Presentation (IP).
2021-12-09 Chinese
110年12月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled or held investor presentation (法人說明會 translates to 'investor presentation' or 'analyst meeting'). It includes company code, name, date, time, location, summary of the presentation, and links to presentation materials in Chinese and English. The content focuses on the announcement and scheduling of an investor presentation event rather than the full report or transcript itself. The document length is short (657 characters), and it primarily serves as an announcement or summary of the investor presentation event. Therefore, the most appropriate classification is Investor Presentation (IP).
2021-12-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.